CPIX
Cumberland Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
7.45 / 10
Outperform
Fund flow metrics are encouraging with a score of 7.45/10, reflecting robust capital movement despite negative trends in block, small, medium, large, and extra-large inflows. The strong fund-flow signal partially offsets technical and fundamental weaknesses, but the absence of analyst coverage (-1) limits the depth of external validation.
Fund Flow Rating
Is money flowing into or out of CPIX?
- CPIX holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.45/10 (Outperform).
